
Santen’s Chief Medical Officer, Peter Sallstig, discusses the company’s latest product news for North America as well as its work across different therapeutic areas.
Santen’s Chief Medical Officer, Peter Sallstig, discusses the company’s latest product news for North America as well as its work across different therapeutic areas.
As a global specialized company dedicated to ophthalmology, Santen brings a 130-year history of scientific knowledge and organizational capabilities to research, development, and commercialization of pharmaceuticals, surgical and medical devices, and OTC eye-care products. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan, and its products now reach patients in more than 60 countries. Santen provides products and services to contribute to the well-being of patients, their loved ones, and consequently to society. For more information, please visit Santen’s websites www.santenusa.com and www.santen.com (Japan headquarters).